Prediction of silent celiac disease at diagnosis of childhood type 1 diabetes by tissue transglutaminase autoantibodies and HLA

Pediatric Diabetes

Volumn 2, Issue 2, 2001, Pages 58-65

  Agardh, Daniel ^a,b   Nilsson, Anita ^b   Tuomi, Tiinamaija ^c   Lindberg, Bengt ^a   Carlsson, Anneli K ^a   Lernmark, Åke ^b,d   Ivarsson, Sten A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Celiac disease; HLA DQ2; Transglutaminase autoantibodies; Type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; ENZYME ANTIBODY; GLIADIN; HLA DQ ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ALLELE; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE PROBE; HLA SYSTEM; HUMAN; HYBRIDIZATION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POLYMERIZATION; PREDICTION; PRIORITY JOURNAL; RADIOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 0034967802     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5448.2001.002002058.x     Document Type: Article

References (54)

1. Revised criteria for diagnosis of coeliac disease
2. The widening spectrum of coeliac disease
3. Relation between gliadin structure and coeliac toxicity
4. Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease
5. Coeliac disease
6. Coeliac disease
7. Coeliac disease and malignancies
8. Malignancy in coeliac disease-effect of a gluten free diet
9. Celiac disease, brain atrophy, and dementia
10. Coeliac disease, epilepsy, and cerebral calcification
11. Does cryptic gluten sensitivity play a part in neurological illness?
12. Non-malignant complications of coeliac disease
13. Female fertility, obstetric and gynaecological history in coeliac disease: A case control study
14. Coeliac disease in the year 2000: Exploring the iceberg
15. Where have all the American celiacs gone?
16. Epidemic of coeliac disease in Swedish children
17. Preliminary results from follow-up of a large-scale population survey of antibodies to gliadin, reticulin and endomysium
18. Screening for coeliac disease - Has the time come for mass screening?
19. Coeliac disease: Screened by a new strategy
20. Results of coeliac disease screening in Estonia in 1990-1994
21. Increasing incidence of childhood coeliac disease in Sweden. Results of a national study
22. Coeliac disease in children and adolescents with IDDM: Clinical characteristics and response to gluten-free diet
23. Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents
24. Coeliac disease-associated disorders and survival
25. Insulin-dependent diabetes mellitus and coeliac disease
26. Prevalence of coeliac disease in type I diabetes: A multicentre study
27. Autoantibodies and autoimmune disease in young diabetics
28. Coeliac disease: Frequent occurrence after clinical onset of insulin-dependent diabetes mellitus
29. T-cell reactivity to wheat gluten in patients with insulin-dependent diabetes mellitus
30. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease
31. Gluten, major histocompability complex and small intestine
32. HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus
33. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis
34. Prevalence of coeliac disease in diabetic children and adolescents in Sweden
35. Identification of tissue transglutaminase as the autoantigen of celiac disease
36. Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease
37. Autoantibodies to tissue transglutaminase as predictors of celiac disease
38. IgA-tissue transglutaminase (tTG) -antibodies are highly sensitive serum markers for celiac disease
39. Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: Evidence for high diagnostic sensitivity for celiac disease
40. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease
41. Anti-gliadin and antiendomysium antibody determination for coeliac disease
42. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
43. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies
44. Endomysial antibody: Is it the best screening test for coeliac disease?
45. Serological screening of coeliac disease: Choosing the optimal procedure according to various prevalence values
46. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac diseaes: Disappointing in clinical practice
47. Comparative analysis of serologic screening tests for the initial diagnosis of coeliac disease
48. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: An Italian multicentre study
49. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies
50. Tissue transglutaminase antibodies in celiac disease
51. IgA anti-tissue transglutaminase as a diagnostic marker for sensitive enteropathy
52. IgA antibodies to tissue transglutaminase: An effective diagnostic test for celiac disease
53. Evaluation of a high-throughput second antibody radiobinding assay of measuring IgA antibodies to human tissue transglutaminase
54. Prevalence of IgA-antigliadin antibodies and IgA-antiendomysium antibodies related to celiac disease in children with Downs syndrome